NCCN 指南乳腺癌指南4.2022 版.pdf,® NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines ) Breast Cancer Version 4.2022 — June 21, 2022 NCCN.org ® NCCN Guidelines for Patients available at /patients Continue ® ® ® Version 4.2022,
Footnote ttt added:According to the 5th ESO-ESMO international consensus guidelines for advanced breast cancer visceral crisis is defined as: “severe organ dysfunction, as assessed by signs and symptoms, laboratory studies and rapid progression of disease. Viscera...
Footnote i revised: Patients with a known genetic predisposition to breast cancer may have an increased risk of contralateral or ipsilateral breast cancers after breast-conservation therapy.Risk reduction strategies including prophylactic mastectomies should be discusse...
Footnote i revised: Patients with a known genetic predisposition to breast cancer may have an increased risk of contralateral or ipsilateral breast cancers after breast-conservation therapy.Risk reduction strategies including prophylactic mastectomies should be discussed. (Also for subsequent pages) 04 BINV...
Patients with a known genetic predisposition to breast cancer p53基因病理突变(利-弗劳梅尼综合征)(2B类)(参见NCCN遗传/家族高风险评定指南:乳腺癌、卵巢癌和胰腺癌) Pathologic p53 mutation (Li-Fraumeni syndrome) (category 2B) (See NCCN Guidelines for Genetic/Familial High-Risk Assessment: Breast, Ovar...
GAST-1 版本 2.2022, 01/11/22 © 2022 National Comprehensive Cancer Network® (NCCN®), 保留所有权利. 未经 NCCN 明确书面许可,不得以任何形式对本NCCN Guidelines® 及其插图进行复制。 NCCN Guidelines 版本 2.2022 NCCN Guidelines 索引 目录 胃癌 讨论 GAST-1的脚注 a 参见内镜分期和治疗原则 (...
检测方法:FISH、NGS、PCR FDA批准药物:拉罗替尼、恩曲替尼 5. TMB(≥10mut/mb) 检测方法:NGS FDA批准药物:帕博利珠单抗 参考资料: 1.中国临床肿瘤学会(CSCO)乳腺癌诊疗指南2022 2.NCCN Guidelines Version 4.2022 Breast Cancer. 作者:医世象 叶子
The phase II MutHER study of neratinib alone and in combination with fulvestrant in HER2-mutated, non-amplified metastatic breast cancer. Clin Cancer Res. 2022;28(7):1258-1267. doi:10.1158/1078-0432.CCR-21-3418 FDA approves new treatment to reduce the risk of breast cancer returning. News ...
01/11/22©2022NationalComprehensiveCancerNetwork(NCCN),Allrightsreserved.NCCNGuidelinesandthisillustrationmaynotbereproducedinanyformwithouttheexpresswrittenpermissionofNCCN.•8thBulletrevised:Perioperativechemotherapyorpostoperativechemotherapypluschemoradiation4isthepreferredapproachforlocalizedgastriccancer.Perioperative...
版权归©2022NationalComprehensiveCancerNetwork,Inc公司所有。NCCNGuidelinesVersion2.2022乳腺癌NCCN乳腺癌小组成员指南更新概要从NCCN乳腺癌指南中删除了小叶原位癌的建议,参见NCCN乳腺筛查和诊断指南非浸润性乳腺癌:导管原位癌(DCIS)检查和初始治疗(DCIS-1)DCIS术后治疗和监测/随访(DCIS-2)浸润性乳腺癌:临床分期,检查(...